Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

Alexander      Orekhov; Vasily      Sukhorukov; Alexandra      Melnichenko

doi:10.2174/0109298673283640231208103306

Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.

[1]
Sahebkar, A.; Kiani, Z.; Rouhani, M.H.; Mahdavi, A.; Askari, G.; Jamialahmadi, T.; Bagherniya, M. The effect of probiotics on oxidized LDL levels: A systematic review and meta-analysis of clinical trials. Curr. Med. Chem., 2023. [Ahead of Print].
 [http://dx.doi.org/10.2174/0929867331666230815104548] [PMID:  37581525]

[2]
Steinberg, D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem.,  1997, 272(34), 20963-20966.
 [http://dx.doi.org/10.1074/jbc.272.34.20963] [PMID:  9261091]

[3]
Palinski, W.; Rosenfeld, M.E.; Ylä-Herttuala, S.; Gurtner, G.C.; Socher, S.S.; Butler, S.W.; Parthasarathy, S.; Carew, T.E.; Stein-berg, D.; Witztum, J.L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci.,  1989, 86(4), 1372-1376.
 [http://dx.doi.org/10.1073/pnas.86.4.1372] [PMID:  2465552]

[4]
Orekhov, A.N.; Tertov, V.V.; Kabakov, A.E. Adamova IYu; Pokrovsky, S.N.; Smirnov, V.N. Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler. Thromb.,  1991, 11(2), 316-326.
 [http://dx.doi.org/10.1161/01.ATV.11.2.316] [PMID:  1998649]

[5]
Avogaro, P.; Bon, G.B.; Cazzolato, G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis,  1988, 8(1), 79-87.
 [http://dx.doi.org/10.1161/01.ATV.8.1.79] [PMID:  3341993]

[6]
Krauss, R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr. Opin. Lipidol.,  1994, 5(5), 339-349.
 [http://dx.doi.org/10.1097/00041433-199410000-00005] [PMID:  7858908]

[7]
Tertov, V.V.; Sobenin, I.A.; Gabbasov, Z.A.; Popov, E.G.; Jaakkola, O.; Solakivi, T.; Nikkari, T.; Smirnov, V.N.; Orekhov, A.N. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. Lab. Invest.,  1992, 67(5), 665-675.
 [PMID:  1434544]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0109298673283640231208103306	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

Current Medicinal Chemistry

Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

Related Journals

Related Books